Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib

Bex, Axel; F.A. Mulders, Peter; A.S. Jewett, Michael; Wagstaff, John; V. van Thienen, Johannes; U. Blank, Christian; van Velthoven, Roland; del Pilar Laguna, Maria; Wood, Lori; H.E. van Melick, Harm; J.B. Aarts, Maureen; Lattouf, Jean-Baptiste; Powles, Thomas; J. de Jong, Igle; Rottey, Sylvie; Tombal, Bertrand; Marréaud, Sandrine; Collette, Sandra; Collette, Laurence; B.A.G. Haanen, John

doi:10.1001/jamaoncol.2018.5543

Public

Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib

Published in JAMA Oncology • Dec 13, 2018

Authors:

Axel Bex

Peter F.A. Mulders

Michael A.S. Jewett

Abstract

Importance: In clinical practice, patients with primary metastatic renal cell carcinoma (mRCC) have been offered cytoreductive nephrectomy (CN) followed by targeted therapy, but the optimal sequence of surgery and systemic therapy is unknown. Objective: To examine whether a period of sunitinib thera...

Subject

Medicine

Sunitinib

Renal cell carcinoma

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!